<DOC>
	<DOCNO>NCT01907724</DOCNO>
	<brief_summary>The purpose study evaluate potential PK drug-drug interaction IDX719 , simeprevir , TMC647055 low-dose ritonavir ( RTV ) administer combination . Safety tolerability also assess .</brief_summary>
	<brief_title>Drug-Drug Interaction Between IDX719 , Simeprevir , TMC647055 Ritonavir When Administered Combination Healthy Participants ( MK-1894-007 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Simeprevir</mesh_term>
	<criteria>Agrees use double method birth control ( one must barrier ) Screening least 90 day last dose study drug Male participant agree donate sperm Day 1 90 day last dose study drug Is pregnant breastfeeding Has another clinically significant medical condition laboratory abnormality ( )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Chronic hepatitis C</keyword>
	<keyword>Hepatitis C virus</keyword>
	<keyword>HCV</keyword>
</DOC>